Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2005
10/12/2005CN1679759A Analgetic, hemostyptic and antiphlogistic Chinese medicine composition and preparation thereof
10/12/2005CN1679758A Zedoary oil injecting emulsion and preparation thereof
10/12/2005CN1679749A Chinese medicine for treating nasal cavity bleed and preparation thereof
10/12/2005CN1679727A Medicinal preparation for tonifying blood, Yiqi, regulating menses and nourishing face-skin
10/12/2005CN1679682A Hemostatic mastic and formulating method thereof
10/12/2005CN1679667A Guiyuan oral liquid and its preparing process
10/12/2005CN1679664A Capsules made from ginseng and danshen and Chinese holly and their production
10/12/2005CN1679648A Mailuoning injection and its preparation and quality control
10/12/2005CN1679644A Preparation of blood-nourishing Angelica capsule
10/12/2005CN1679642A Oral liquid medicine from ferments of armilarilla tabescens
10/12/2005CN1679639A Oral soft capsule of medicinal preparation from blood-activating Chinese medicine pseudo-ginseng and leech extract
10/12/2005CN1679637A Biological medicine for treating diseases from infection viral and bacterial
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1679521A Use of substituting nitrobenzene derivative in products preparation
10/12/2005CN1222617C Chemotactic factor receptos 88-2B [CKR-3] and 88C and their antibodies
10/12/2005CN1222537C Preparing process for Eptifibatide
10/12/2005CN1222527C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
10/12/2005CN1222520C Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
10/12/2005CN1222312C Fibrin ferment hemostatic suppository
10/12/2005CN1222311C Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953854 Process for preparing crystalline Form I of cabergoline
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/11/2005US6953837 Factor VIII/vWF complexes and compositions
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953798 compounds are able to inhibit binding of alpha 4 integrins to their ligands and are of use in prophylaxis and treatment of immune or inflammatory disorders
10/11/2005US6953791 Dipeptide derivatives
10/11/2005US6953778 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
10/11/2005US6953674 Inhibitors of human plasmin derived from the kunitz domains
10/11/2005US6953670 Methods for identifying compounds capable of supplementing the biological activity of leptin
10/11/2005US6953568 Administering biological conjugates that bind preferentially to endothelial protein C receptor(EPCR), to endothelial cells of vascular systems; genetic translocation; drug delivery
10/11/2005CA2341276C Human anti-factor ix/ixa antibodies
10/06/2005WO2005093064A1 Novel galectin 9 modification protein and use thereof
10/06/2005WO2005092348A1 Hgf production accelerator containing heparin-like oligosaccharide
10/06/2005US20050222653 Indwelling heat exchange catheter and method of using same
10/06/2005US20050222418 Novel tyloindicines and related processes, pharmaceutical compositions and methods
10/06/2005US20050222395 New peptide derivatives
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222244 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
10/06/2005US20050222216 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222179 Adenosine receptor antagonists and methods of making and using the same
10/06/2005US20050222170 In combination with organic nitrate or nitric oxide donors or inhibitors of cyclic GMP metabolism; erectile dysfunction or female sexual dysfunction
10/06/2005US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
10/06/2005US20050222137 Combination of organic compounds
10/06/2005US20050222114 Use of new etonogestrel esters
10/06/2005US20050222087 Hedgehog antagonists that inhibit the hedgehog pathway in a smoothened gain-of-function cell with an IC50 within a factor of 20, 10, or even a factor of 5, of the IC50 with which they inhibit the hedgehog pathway in a patched-null cell
10/06/2005US20050222079 Preparation containing folic acid, vitamin b6, and vitamin b12, and use thereof
10/06/2005US20050222025 Method of inhibiting fibrosis with a somatostatin agonist
10/06/2005US20050222024 Stabilized albumin preparations
10/06/2005US20050222010 Composition for treating or preventing hyperuricemia
10/06/2005US20050221368 Methods for identifying RNA binding compounds
10/06/2005US20050221355 cDNA for human methylenetetrahydrofolate reductase and uses thereof
10/06/2005US20050221287 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
10/06/2005US20050220819 Novel binding epitopes for helicobacter pylori and use thereof
10/06/2005US20050220790 Amino-terminally truncated rantes as chemokine antagonists
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005US20050220780 Pharmaceutical composition having thrombolytic anti-inflammatory and cytoprotective properties
10/06/2005US20050217596 Novel health food and drink containing marine algae
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2561057A1 Prolinyl derivatives for treating thrombosis
10/06/2005CA2534445A1 Agent for promoting hgf production comprising heparin-like oligosaccharides
10/05/2005EP1582586A1 Apoptosis-associated protein and use thereof
10/05/2005EP1582521A1 Fused furan compound
10/05/2005EP1582517A1 Blood-brain barrier disruption inhibitors
10/05/2005EP1581614A2 Nucleotide sequences for gene regulation and methods of use thereof
10/05/2005EP1581560A1 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof
10/05/2005EP1581527A2 Thrombopoietin mimetics
10/05/2005EP1581523A1 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
10/05/2005EP1581493A1 Factor xa inhibitors
10/05/2005EP1581255A1 An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism
10/05/2005EP1581239A1 Method of improvement of blood circulation
10/05/2005EP1581222A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-&bgr;
10/05/2005EP1581165A2 Novel factor viia inhibiting compounds
10/05/2005EP1325008B1 Piperazine derivatives
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005EP1233950B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1077936B1 Novel analogs of 16-hydroxyeicosatetraenoic acid
10/05/2005EP0990002B1 Dextran derivatives, preparation method and applications as medicine with specific biological action
10/05/2005CN1678636A Thrombus-resolving and anticoagulation double function fusion protein and use thereof
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678348A Compositions and methods for therapeutic treatment
10/05/2005CN1678341A Use of erythopoietin
10/05/2005CN1678332A Novel therapeutic use of polypodium extracts
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1676530A Matrimony vine arabinogalactan protein, and its preparing process, use and composition
10/05/2005CN1676520A Kuh-seng flavone extract and preparation and use thereof
10/05/2005CN1676508A Anti-inflammatory and anti-thrombus compound and its medicinal composition
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221281C Oral, nasal and pulmonary dosage formulations of copolymer1
10/04/2005US6951939 Multivalent platform molecules comprising high molecular weight polyethylene oxide
10/04/2005US6951916 Melanocortin receptor ligands
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951874 Compounds
1 ... 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 ... 671